Consequence of reimbursement policy alteration for urgent PCI in Japan

Nobuhiro Ikemura; Mitsuaki Sawano; Ikuko Ueda; Keiichi Fukuda; Shun Kohsaka

doi:10.1016/S0140-6736(18)30857-2

Consequence of reimbursement policy alteration for urgent PCI in Japan

Nobuhiro Ikemura, Mitsuaki Sawano, Ikuko Ueda, Keiichi Fukuda, Shun Kohsaka

Department of Internal Medicine (Cardiology)

Research output: Contribution to journal › Letter › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	2208-2209
Number of pages	2
Journal	The Lancet
Volume	391
Issue number	10136
DOIs	https://doi.org/10.1016/S0140-6736(18)30857-2
Publication status	Published - 2018 Jun 2

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/S0140-6736(18)30857-2

Cite this

@article{47fc90fe92784e8987d27aa422ed1122,

title = "Consequence of reimbursement policy alteration for urgent PCI in Japan",

author = "Nobuhiro Ikemura and Mitsuaki Sawano and Ikuko Ueda and Keiichi Fukuda and Shun Kohsaka",

note = "Funding Information: SK received an unrestricted research grant for the Department of Cardiology at Keio University School of Medicine from Bayer Pharmaceutical and Daichi Sankyo. All other authors declare no competing interests. This research was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI No. 16H05215, 25460630, and 25460777) and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.",

year = "2018",

month = jun,

day = "2",

doi = "10.1016/S0140-6736(18)30857-2",

language = "English",

volume = "391",

pages = "2208--2209",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10136",

}

TY - JOUR

T1 - Consequence of reimbursement policy alteration for urgent PCI in Japan

AU - Ikemura, Nobuhiro

AU - Sawano, Mitsuaki

AU - Ueda, Ikuko

AU - Fukuda, Keiichi

AU - Kohsaka, Shun

N1 - Funding Information: SK received an unrestricted research grant for the Department of Cardiology at Keio University School of Medicine from Bayer Pharmaceutical and Daichi Sankyo. All other authors declare no competing interests. This research was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI No. 16H05215, 25460630, and 25460777) and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.

PY - 2018/6/2

Y1 - 2018/6/2

UR - http://www.scopus.com/inward/record.url?scp=85047734072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047734072&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(18)30857-2

DO - 10.1016/S0140-6736(18)30857-2

M3 - Letter

C2 - 29893216

AN - SCOPUS:85047734072

SN - 0140-6736

VL - 391

SP - 2208

EP - 2209

JO - The Lancet

JF - The Lancet

IS - 10136

ER -

Consequence of reimbursement policy alteration for urgent PCI in Japan

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this